Oral fenofibrate (10 mg/kg) acts as an effective adjunct to phototherapy in term neonates with hyperbilirubinemia, significantly reducing total serum bilirubin (TSB) levels. It works by inducing glucuronyl transferase activity, boosting bilirubin conjugation and excretion. Studies show it is safe, reduces hospital stay duration, and significantly lowers bilirubin levels within 24 to 48 hours.
No major side effects were reported with a single dose.
No comments:
Post a Comment